Resultados da pesquisa - Felices, Martin
- A mostrar 1 - 20 resultados de 44
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker Por Schmohl, Joerg U, Felices, Martin, Taras, Elizabeth, Miller, Jeff S, Vallera, Daniel A
Publicado em 2016Text -
7
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT) Por Foley, Bree, Felices, Martin, Cichocki, Frank, Cooley, Sarah, Verneris, Michael R., Miller, Jeffrey S.
Publicado em 2014Text -
8
-
9
-
10
-
11
-
12
Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker Por Schmohl, Joerg U., Felices, Martin, Todhunter, Deborah, Taras, Elizabeth, Miller, Jeffrey S., Vallera, Daniel A.
Publicado em 2016Text -
13
-
14
-
15
A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer Por Vallera, Daniel A., Oh, Felix, Kodal, Behiye, Hinderlie, Peter, Geller, Melissa A., Miller, Jeffrey S., Felices, Martin
Publicado em 2021Text -
16
-
17
Notch signaling at later stages of Natural Killer cell development enhances KIR expression and functional maturation Por Felices, Martin, Ankarlo, Dave E.M., Lenvik, Todd R., Nelson, Heather H., Blazar, Bruce R., Verneris, Michael R., Miller, Jeffrey S.
Publicado em 2014Text -
18
Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity Por Schmohl, Jörg U., Felices, Martin, Oh, Felix, Lenvik, Alexander J., Lebeau, Aaron M., Panyam, Jayanth, Miller, Jeffrey S., Vallera, Daniel A.
Publicado em 2017Text -
19
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells Por Don Yun, Hyun, Felices, Martin, Vallera, Daniel A., Hinderlie, Peter, Cooley, Sarah, Arock, Michel, Gotlib, Jason, Ustun, Celalettin, Miller, Jeffrey S.
Publicado em 2018Text -
20
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL Por Felices, Martin, Kodal, Behiye, Hinderlie, Peter, Kaminski, Michael F., Cooley, Sarah, Weisdorf, Daniel J., Vallera, Daniel A., Miller, Jeffrey S., Bachanova, Veronika
Publicado em 2019Text